Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.
about
The Renin-Angiotensin-aldosterone system in vascular inflammation and remodelingHuman tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathwaysCellular mediators of renal vascular dysfunction in hypertensionDefects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndromePollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptorG-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingUnderstanding and treating hypertension in diabetic populationsMolecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 DiabetesNOX signaling in molecular cardiovascular mechanisms involved in the blood pressure homeostasisTargeting G protein coupled receptor-related pathways as emerging molecular therapiesAngiotensin II, NADPH oxidase, and redox signaling in the vasculatureThe role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing actEpac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migrationAngiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generationAngiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signalingRegulation of coronary arterial BK channels by caveolae-mediated angiotensin II signaling in diabetes mellitusIdentification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth musclesAngiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cellsEnhancement of mesenteric artery contraction to 5-HT depends on Rho kinase and Src kinase pathways in the ob/ob mouse model of type 2 diabetesPDGF-dependent regulation of regulator of G protein signaling-5 expression and vascular smooth muscle cell functionality.Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndromeRoles of Na⁺/H⁺ exchanger type 1 and intracellular pH in angiotensin II-induced reactive oxygen species generation and podocyte apoptosis.Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivationFemale spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than malesCalmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy.Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration.Early life stress sensitizes rats to angiotensin II-induced hypertension and vascular inflammation in adult life.Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin IIEnhanced sensitivity to acute angiotensin II is testosterone dependent in adult male growth-restricted offspringAscorbate improves circulation in postural tachycardia syndrome.Independent and combined influence of AGTR1 variants and aerobic exercise on oxidative stress in hypertensives.Store-operated Ca(2+) entry is not essential for PDGF-BB induced phenotype modulation in rat aortic smooth muscleMalaria and hypertension. Another co-evolutionary adaptation?Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.The angiotensin II type 1 receptor (AT1R) closely interacts with large conductance voltage- and Ca2+-activated K+ (BK) channels and inhibits their activity independent of G-protein activation.Local regulation of arterial L-type calcium channels by reactive oxygen species.Perinatal nicotine exposure increases angiotensin II receptor-mediated vascular contractility in adult offspring.
P2860
Q21284671-D60EA521-0914-4DA4-9FAF-E9DD9621B8C9Q24303697-49418C2D-2C09-40D6-81FA-DC22560D0AB5Q24644250-4868108A-AAB0-4BEA-867C-D2DECB04A7F5Q24650489-0428EF7A-B4C3-4349-8014-69F156F677BCQ24815241-ED3CDE40-418C-4D99-B2A0-FFB9CA5C149FQ26772221-D0F477D6-FA29-4915-A289-EC061DD96039Q26778662-6D02E7AA-0623-49E8-B06E-AB178986BBA8Q26782445-A7389F42-42D4-4DBF-B0C8-E48DA5F8FAECQ26798744-FFE40E8B-D66A-43F8-A823-E4F0A17854F8Q26829964-61507E6A-9364-4042-B63E-3C1DEBA785EAQ26998758-32197D93-C07B-4AB4-BE29-077F0A5DD009Q27013946-6D6D544D-3B87-45AC-863A-48B29595B0FCQ28390079-7E30E7DE-D8B9-478F-A8C5-494F60BA40E3Q28570215-02405C1C-D8CD-4AFE-9307-5EBCDBE62E9EQ28571898-D96E4CE0-3DA0-4844-8DFC-B71599AF7D85Q28575995-BEB50170-16C9-4F38-A0A3-4E1FA317CDBCQ28576742-9BF6BDE3-7727-481F-B605-A38EE340E42DQ28577952-BF10D5A5-4E9E-4139-BD4E-63D2BE8967B5Q28582292-7720C240-6DE2-4382-B966-0552E9C28C0BQ28749389-2D4A7C80-5238-4054-A0B7-A513FECA1823Q30425676-5D325E9A-E5EC-48E7-AAF6-2A08268EC8C6Q30429420-F5D38601-F4CA-4549-A249-D86629E6076CQ30445038-7E498D14-B057-433F-948A-378F01F213E7Q30836315-F8CC3900-5D10-442F-A362-5F739FCE2A28Q31122004-57690738-E343-43B0-A051-3D83326CAC7BQ33574889-C562A43A-B2C2-4C95-BC0E-31B4928A08E4Q33626600-1AC4E2B9-A038-4DF5-B361-E9EA0010F185Q33655919-A1CBAFC1-A45F-4900-A286-55549F730135Q33680255-3AEA3C01-CD8A-4149-83EC-3D32023AA06DQ33690912-FFE13CE6-9B7C-4EF6-BE4F-B54078A2A871Q33769656-21374F48-3A4F-4F07-AA37-7B0B141D6B25Q33841029-6EF0EFC4-0AC3-4124-8F08-48319E077AB9Q33915381-0F6CC907-75EB-4214-AD10-99E667C36884Q34069005-7E36CEEF-415B-40BD-9975-6196F218A1BDQ34088507-A2F629FF-8089-419D-91E6-8939CDD7B902Q34127049-42313E61-F0BD-4982-9348-B71FF7538975Q34150434-584819BA-BA5B-4B12-A64F-9809CA31F773Q34170731-8F8215BC-C316-425E-889D-BCA6C619DEC2Q34257440-FDD38DB9-2AB4-4EBA-B881-5A437EB3856FQ34263830-7AA21A5D-6745-4BE0-B823-447C419E2BFA
P2860
Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Signal transduction mechanisms ...... vascular smooth muscle cells.
@ast
Signal transduction mechanisms ...... vascular smooth muscle cells.
@en
Signal transduction mechanisms ...... vascular smooth muscle cells.
@nl
type
label
Signal transduction mechanisms ...... vascular smooth muscle cells.
@ast
Signal transduction mechanisms ...... vascular smooth muscle cells.
@en
Signal transduction mechanisms ...... vascular smooth muscle cells.
@nl
prefLabel
Signal transduction mechanisms ...... vascular smooth muscle cells.
@ast
Signal transduction mechanisms ...... vascular smooth muscle cells.
@en
Signal transduction mechanisms ...... vascular smooth muscle cells.
@nl
P1476
Signal transduction mechanisms ...... n vascular smooth muscle cells
@en
P2093
Schiffrin EL
P304
P577
2000-12-01T00:00:00Z